With changes in demographics and advancements in cancer care, the current oncologist workforce is expected to experience an ...
Placebo-Controlled Trial” (Journal of Clinical Oncology 10.1200/JCO.24.00381) was published online September 10, 2024, with errors. Typographical errors were present in the PAC-QOL row of Table 2 ...
Dr. Shivaani Kummar is stepping into the role of OHSU Knight Cancer Institute chief executive on an interim basis, OHSU ...
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has reported its financial results for the year ending December ...
Rodabe Amaria, MD, discusses the current role of OBX-115 for the treatment of patients with checkpoint inhibitor-resistant metastatic melanoma.
Dr. Joyce A. O’Shaughnessy, described by her peers as a ‘legend in the space,’ leads breast cancer research and treatment ...
Clinical Trials Arena on MSN3d
Flatiron and NRG Oncology to deploy EHR-to-EDC technology in multi-centre trialThe entities will undertake a trial to assess the efficiency of the technology against traditional data entry methods.
Founded in 1998 by Neal Shore, MD, FACS, CURC has conducted nearly 500 clinical trials, making it the top urologic oncology site worldwide by both volume and quality. With deep expertise in early ...
– VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival – – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback